ADAP Advocacy, a drug industry funded group, recently released a minute-long ad that argues 340B unduly benefits providers and could be rife with “fraud, waste and abuse.”

Drug Industry-Backed AIDS Group Targets 340B in New Ad Campaign

May 20, 2025 Shannon Young, Associate Editor/Senior Writer Views

A pharmaceutical industry-funded HIV/AIDS advocacy group is taking aim at the 340B program—questioning if it’s “too big to fail”—in a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Drug Industry-Backed AIDS Group Targets 340B in New Ad Campaign

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Drug Industry-Backed AIDS Group Targets 340B in New Ad Campaign

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Site Footer Live